KMED Stock Overview
KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF is an exchange traded fund launched and managed by Krane Funds Advisors, LLC.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$18.81 |
52 Week High | US$23.64 |
52 Week Low | US$18.50 |
Beta | 0 |
1 Month Change | -4.64% |
3 Month Change | -9.72% |
1 Year Change | -8.54% |
3 Year Change | -38.53% |
5 Year Change | -8.87% |
Change since IPO | -24.88% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
KMED | US Capital Markets | US Market | |
---|---|---|---|
7D | -2.9% | -0.7% | -3.2% |
1Y | -8.5% | 23.2% | 19.3% |
Return vs Industry: KMED underperformed the US Capital Markets industry which returned 8.2% over the past year.
Return vs Market: KMED underperformed the US Market which returned 16% over the past year.
Price Volatility
KMED volatility | |
---|---|
KMED Average Weekly Movement | 2.5% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KMED has not had significant price volatility in the past 3 months.
Volatility Over Time: KMED's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | n/a | n/a | kraneshares.com/kmed/ |
KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF is an exchange traded fund launched and managed by Krane Funds Advisors, LLC. It invests in public equity markets of global emerging region. It invests in stocks of companies operating across health care sectors.
KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF Fundamentals Summary
KMED fundamental statistics | |
---|---|
Market cap | US$1.88m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs KMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KMED income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did KMED perform over the long term?
See historical performance and comparison